Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 3/20 | 0.43 |
| ▸ | CHRNA4 | P43681 | 3/20 | 0.43 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.40 |
| ▸ | LTA4H | P09960 | 2/20 | 0.38 |
| ▸ | CXCR1 | P25024 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3662113 | 0.79 | CHRNA3 (0.51) | CHRNB2CHRNA4 | |
| Hydrochloric Acid SCHEMBL7666384 | 0.78 | CHRNB2 (0.51) | CHRNB2CHRNA4HRH3LTA4HKMT2A | |
| Hydrochloric Acid SCHEMBL7663501 | 0.78 | CHRNA3 (0.50) | CHRNB2CHRNA4 | |
| Hydrochloric Acid SCHEMBL7674172 | 0.78 | CHRNA3 (0.50) | CHRNB2CHRNA4 | |
| SCHEMBL7462908 | 0.76 | CHRNA3 (0.51) | CHRNB2CHRNA4 | |
| SCHEMBL3163559 | 0.73 | HRH3 (0.63) | HRH3LTA4HCXCR1MEN1LMNA | |
| SCHEMBL3223854 | 0.72 | CHRNB2 (0.67) | CHRNB2CHRNA4LTA4H | |
| SCHEMBL7479403 | 0.72 | CXCR1 (0.35) | CHRNB2CHRNA4HRH3CXCR1 | |
| SCHEMBL7404714 | 0.71 | GRM5 (0.38) | CHRNB2CHRNA4 | |
| Hydrochloric Acid SCHEMBL7464431 | 0.70 | CHRNB2 (0.37) | CHRNB2CHRNA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0950057-B1 | 3-PYRIDYL ENANTIOMERS AND THEIR USE AS ANALGESICS | ABBOTT LAB (US) | 2002-11-13 | — | — | EP | claimed |
| US-6133253-A | NEURONAL CELL DEATH PREVENTORS AND ANTI-INFLAMMATORIES | ABBOTT LABORATORIES (US) | 2000-10-17 | — | — | US | claimed |
| EP-0950057-A1 | 3-PYRIDYL ENANTIOMERS AND THEIR USE AS ANALGESICS | Abbott Laboratories (US) | 1999-10-20 | — | — | EP | claimed |
| WO-1998025920-A1 | 3-PYRIDYL ENANTIOMERS AND THEIR USE AS ANALGESICS | ABBOTT LABORATORIES (US) | 1998-06-18 | — | — | WO | claimed |
| EP-2559427-A1 | Transdermal therapeutic system having a content of a modulator for nicotinic acetylcholine receptors (nAChR) | Acino AG (DE) | 2013-02-20 | — | — | EP | disclosed |
| EP-2217206-A2 | TRANSDERMAL THERAPEUTIC SYSTEM HAVING A CONTENT OF A MODULATOR FOR NICOTINIC ACETYLCHOLINE RECEPTORS (NACHR) | Acino AG (DE) | 2010-08-18 | — | — | EP | disclosed |
| WO-2009071326-A2 | TRANSDERMAL THERAPEUTIC SYSTEM HAVING A CONTENT OF A MODULATOR FOR NICOTINIC ACETYLCHOLINE RECEPTORS (NACHR) | ACINO AG (DE) | 2009-06-11 | — | — | WO | disclosed |
| EP-0950057-B1 | 3-PYRIDYL ENANTIOMERS AND THEIR USE AS ANALGESICS | ABBOTT LAB (US) | 2002-11-13 | — | — | EP | disclosed |
| US-6403575-B1 | ANTI-INFLAMMATORIES | ABBOTT LABORATORIES | 2002-06-11 | — | — | US | disclosed |
| EP-1086076-A1 | SULFONAMIDE INHIBITORS OF ASPARTYL PROTEASE | Vertex Pharmaceuticals Incorporated (US) | 2001-03-28 | — | — | EP | disclosed |
| EP-1047690-A1 | HETEROCYCLIC ETHER AND THIOETHER COMPOUNDS USEFUL IN CONTROLLING CHEMICAL SYNAPTIC TRANSMISSION | Abbott Laboratories (US) | 2000-11-02 | — | — | EP | disclosed |
| US-6133253-A | NEURONAL CELL DEATH PREVENTORS AND ANTI-INFLAMMATORIES | ABBOTT LABORATORIES (US) | 2000-10-17 | — | — | US | disclosed |
| WO-1999065870-A2 | SULFONAMIDE INHIBITORS OF ASPARTYL PROTEASE | VERTEX PHARMACEUTICALS INCORPORATED (US) | 1999-12-23 | — | — | WO | disclosed |
| EP-0950057-A1 | 3-PYRIDYL ENANTIOMERS AND THEIR USE AS ANALGESICS | Abbott Laboratories (US) | 1999-10-20 | — | — | EP | disclosed |
| WO-1999032480-A1 | HETEROCYCLIC ETHER AND THIOETHER COMPOUNDS USEFUL IN CONTROLLING CHEMICAL SYNAPTIC TRANSMISSION | ABBOTT LABORATORIES (US) | 1999-07-01 | — | — | WO | disclosed |
| WO-1998025920-A1 | 3-PYRIDYL ENANTIOMERS AND THEIR USE AS ANALGESICS | ABBOTT LABORATORIES (US) | 1998-06-18 | — | — | WO | disclosed |